Primary infantile hypomagnesaemia was first described by Miller (1944) and was first attributed to a specific intestinal defect for magnesium transport by Paunier et al. (1968) . It has not previously been described in association with hypercalcaemia in man. This patient also had elevated levels of 25 OH cholecalciferol and there was evidence of both intestinal and renal tubular defects of magnesium transport.
Case reports
Magnesium transport defect with hypercalcaemia 1 H M Nutbeam MRCP DCH L Sinclair MB FRCP V G Oberholzer BA St Stephen's Hospital, London SWlO 9TH Primary infantile hypomagnesaemia was first described by Miller (1944) and was first attributed to a specific intestinal defect for magnesium transport by Paunier et al. (1968) . It has not previously been described in association with hypercalcaemia in man. This patient also had elevated levels of 25 OH cholecalciferol and there was evidence of both intestinal and renal tubular defects of magnesium transport.
Case history M S, the mother's first child, was born normally on 21 August 1977. The birth weight was 2.5 kg at 39 weeks gestation. At 24 hours of age he became irritable. The blood glucose was 1.2 mmol/l and he was treated with oral glucose supplements. The serum calcium was 2.3 mmol/l and serum magnesium 0.8 mmol/l, He remained irritable and treatment with phenytoin 3 mg eight-hourly was begun. He was discharged aged 20 days, weighing 3.060 kg and receiving phenytoin and compound vitamin drops 0.3 ml daily. He was readmitted at six weeks of age with spontaneous muscular spasms and anaemia.
The results of investigations included normal serum electrolytes (Na 137 mmol/l, K 4.9 mmol/l, CIIOO mmol/l, HC0 3 23 mmol/l, urea 4.0 mmol/l) and normal liver function tests;
protein 62 gil, albumin 45 gil. Immunoglobulins, amino acids and thyroid function were normal as were the chest X-ray, skull X-rays, IVP and EEG. The haemoglobin was 10.1 g/dl with evidence of iron deficiency. The serum iron was 3 umol/l (normal 10 -30) and total iron binding capacity 78 umol/I (normal 45 -70). The iron absorption test showed adequate absorption (fasting serum iron was 5 umol/l following 0.45 mmol of ferrous iron orally as ferrous amino aceto-sulphate level at 2h was 70 umol and at 4 hours 45 umol/l). (Figure 1 )showed no elevation after 2.6 mmol magnesium chloride orally. Therapy with oral magnesium hydroxide for one week caused diarrhoea and a magnesium oxide mixture containing light magnesium oxide and calcium lactate was also followed by hypercalcaemia which persisted after its withdrawal. Magnesium chloride was then introduced, but this failed to maintain serum magnesium levels and caused diarrhoea. He was eventually started on intramuscular magnesium sulphate 0.41 mmol/kg per day. Magnesium balance studies were carried out while on this treatment on a measured magnesium intake (Table 2) . These showed high faecal losses of magnesium (79% of oral intake) and increased magnesium retention, the latter including intramuscular magnesium. Magnesium infusion studies were carried out (Figure 2) using magnesium chloride 5.2Ilmol/kg infused over 90 minutes (Thoren's test) . Intramuscular magnesium had previously been discontinued for one week. 24-hour urinary magnesium prior to magnesium infusion (when serum levels of magnesium were low) was within the normal range described for children with normal serum levels. Following infusion 18% of the load was excreted during the first four hours but a total of 80% over the 24-hour period. The patient is now maintained on intramuscular magnesium sulphate 4.1 mmol every third day. Magnesium levels are satisfactory following the intramuscular injection (0.8 -0.9 mmol/l) but low in the fasting state prior to injection (0.57 -0.6 mmol/l). Serum calcium and 25 OH cholecalciferol levels remain raised. There are no symptoms and growth and development are normal.
Discussion
There have been 12previously reported cases of magnesium malabsorption due to an intestinal transport defect. Apart from one (Haijamae & MacDowall 1972) , these cases have all been males, but family involvement has been noted (Salet et al. 1970 , Stromme et al. 1969 and inheritance is thought to be autosomal recessive.
The clinical features are hyperirritability, increased muscle tone, convulsions, failure to thrive, and diarrhoea. Late signs are weakness, sweating, hypothermia, hypotension, and apnoea. Anaemia and hypoproteinaemia (Smales 1974) have also been described. All previously reported cases have had low or normal serum calcium levels. In our patient, the serum magnesium was in the low normal range at birth. Six weeks later it was low and associated with clinical signs. The calcium level was noted to be high at seven weeks of age. This may have been related to discontinuation of the phenytoin, which has a hypocalcaemic effect. The oral magnesium absorption test was flat. This evidence was supported by the magnesium balance studies. 79% of the oral intake was excreted in the stools (normal range 25 -40%). Retention was 33%(0.16 mmol/kg) (normal range 0.04 -0.121 mrnol/kg) suggesting total body depletion of magnesium.
The intravenous magnesium loading test (Caddell 1975 , Thoren 1963 showed low serum levels of magnesium prior to infusion, but these rose to normal levels during the infusion. At four hours levels were again low. The serum calcium remained unchanged. 24-hour urine levels prior to infusion (when serum levels of magnesium were low) were within the range described for children with normal serum levels (Ghazali & Barratt 1974 )and higher than one might expect for a child with low serum levels. Urinary excretion was 18%over the first four hours but 80% over 24 hours. This was despite a fall in serum magnesium to low levels four hours after infusion. The four-hour retention (normal excretion 70 -80% in four hours) suggests a state of total body magnesium depletion, but since excretion continued and levels remained high 24 hours following the infusion, the evidence points to a renal magnesium transport defect.
This patient therefore seems to have an intestinal transport defect for magnesium combined with a possible renal tubular transport defect. The latter was described in a 3-year-old girl (Booth & Johnson 1974) but the two, with hypercalcaemia and raised levels of 25 OH cholecalciferol, have never been previously reported. Hypomagnesaemia with hypercalcaemia was described in rats on low magnesium diets (MacIntyre & Davidson 1958) . This was attributed to increased activity of the parathyroid gland in response to the low magnesium level, causing increased intestinal absorption of calcium. Our patient's parathyroid hormone level was normal. It has also been suggested that there may be a common transport mechanism in the gut for calcium and magnesium with reduced competition from magnesium causing enhanced calcium absorption and it is also possible that this common transport mechanism may operate in the kidneys.
